Swiss Equity Magazin (NZZ magazine for successful companies)

18 February 2011

“Swiss Equity magazin”, the NZZ magazine for successful enterprises, reports about Malcisbo as newcomer.

Poulet-Schmaus ohne Gesundheitsrisiko
Sieben von zehn Schlachthühnern sind von einem Bakterium befallen, das beim Menschen schwere Uebelkeit verursachen kann. Das Unternehmen Malcisbo will dagegen einen Hühner-Impfstoff entwickeln.

(Source: Swiss Equity magazin_2/11)

Pdf

Swiss Equity magazin

 

Latest News

  • 21 January 2019

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2019)

  • 26 November 2018

    VetBioNet grant

    Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)